S100 Calcium Binding Protein (S100): A Potential Drug Target and Biomarker

Target Name: S100 Calcium Binding Protein

NCBI ID: P26976

S100 Calcium Binding Protein

Other Name(s): S100 | S100 Calcium Binding Protein

S100 Calcium Binding Protein (S100): A Potential Drug Target and Biomarker

S100 Calcium Binding Protein (nonspecified subtype) (S100) is a protein that is expressed in various tissues and cells in the human body. It is a member of the S100 family of proteins, which are known for their ability to interact with calcium ions and play important roles in various cellular processes, including cell signaling, muscle contractions, and nerve function. S100 is a glycoprotein with a molecular weight of approximately 180 kDa. It consists of two distinct chains, designated as chain A and chain B, which are held together by a disulfide bond.

S100 has been identified as a potential drug target and biomarker due to its unique structure and various cellular functions. S100 has been shown to play important roles in various physiological processes, including cell signaling, inflammation, and neurodegeneration. Its interaction with calcium ions has been shown to play a critical role in these processes.

Drug Target Potential

S100 has been identified as a potential drug target due to its unique structure and various cellular functions. S100 has been shown to play important roles in various physiological processes, including cell signaling, inflammation, and neurodegeneration. Its interaction with calcium ions has been shown to play a critical role in these processes.

One of the key features that makes S100 an attractive drug target is its ability to interact with a variety of molecules, including calcium ions, phosphates, and nucleotides. This interactivity makes S100 a potentially versatile target for small molecules, antibodies, or other therapeutic agents.

In addition to its potential as a drug target, S100 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes S100 an attractive target for diagnostic applications, as well as for the development of new therapeutic approaches.

Biomarker Potential

S100 has been shown to play important roles in various physiological processes, including cell signaling, inflammation, and neurodegeneration. Its interaction with calcium ions has been shown to play a critical role in these processes. This makes S100 an attractive biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key advantages of S100 as a biomarker is its ability to be easily modified and used in a variety of assays, including Western blotting, immunofluorescence, and biochemical assays. This makes it possible to use S100 as a marker for a wide range of cellular and molecular processes, including the detection and quantification of protein expression, as well as the determination of protein-protein interactions and other cellular interactions.

In addition to its use as a biomarker, S100 has also been shown to be involved in the development of various diseases, including cancer and neurodegenerative diseases. For example, studies have shown that S100 is overexpressed in various cancer tissues and that its levels are associated with cancer progression. Similarly, S100 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.

Conclusion

S100 Calcium Binding Protein (nonspecified subtype) (S100) is a protein that has been identified as a potential drug target and biomarker due to its unique structure and various cellular functions. S100 has been shown to play important roles in various physiological processes, including cell signaling, inflammation, and neurodegeneration. Its interaction with calcium ions has been shown to play a critical role in these processes.

Furthermore, S100 has been shown to be a potential drug target due to its ability to interact with a variety of molecules, including calcium ions, phosphates, and nucleotides. Additionally, S100 has also been shown to be a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Overall, the unique structure and various cellular functions of S100 make it an attractive target for small molecules, antibodies, or other therapeutic agents. Its potential as a drug target and biomarker make S100 a promising agent for the development of new therapeutic approaches for a variety of diseases.

Protein Name: S100 Calcium Binding Protein (nonspecified Subtype)

The "S100 Calcium Binding Protein Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about S100 Calcium Binding Protein comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets